The company's documented U.S. regulatory footprint in the supplied filings is a single 510(k) record, K262812, received by FDA on August 7, 2026 and decided on October 5, 2026. The applicant name on that record is Sichuan Qianli-Beoka Medical Technology, Inc., with a Chengdu, China filing address. The device is listed as a Class II Physical Medicine product under 21 CFR 890.5650, product code IRP, cleared through the Traditional 510(k) pathway with a Summary statement rather than a third-party review. [1][5][9]

The cleared device and its model designations

K262812 covers an air compression massager listed under eighteen model designations: ACM-C1, ACM-C2, ACM-C3, ACM-C4, ACM-C5, ACM-C6, ACM-C7, ACM-C8, ACM-C9, ACM-5C1, ACM-5C2, ACM-5C3, ACM-5C4, ACM-5C5, ACM-5C6, ACM-5C7, ACM-5C8 and ACM-5C9. FDA classifies the device as a Massager, Powered Inflatable Tube, device class 2, regulation number 890.5650, within the Physical Medicine advisory committee. The clearance type is Traditional, and the record indicates a Summary was submitted. [1][5][8]

A device description published by Innolitics states that the product is a powered inflatable tube massager intended to temporarily relieve minor muscle aches and pains and to temporarily increase circulation to treated areas, simulating manual kneading and stroking of tissues with an inflatable pressure cuff. That description also states the devices are for people in good health, are powered by an internal rechargeable lithium-ion battery, and use a button interface with a small display screen showing treatment time and pressure level. These are the publisher's characterizations of the device, not independent test results. [4]

Filing timeline and review record

The 510(k) was received on August 7, 2026 and decided on October 5, 2026, a decision of Substantially Equivalent (SESE). FDA's final-decision listing for October 2026 records K262812 with that decision and applicant name. A third-party database calculates the interval as a 59-day FDA review; that figure is the database's own arithmetic on the two FDA dates rather than an FDA-stated review metric. [1][3][7]

The submission was not reviewed by a third party, was not a combination product, and had no authorized Predetermined Change Control Plan, according to the FDA 510(k) database page for K262812. The page carries a last-updated date of October 26, 2026. [2]

Applicant identity and what the record does not establish

The applicant of record is Sichuan Qianli-Beoka Medical Technology, Inc., with a filing address on Longtan Industrial Park 2nd Sec, E. 3rd Ring Rd., Chenghua District, Chengdu, postal code 610052, country code CN. That address appears in the FDA record as a correspondence address; it is not evidence of a corporate headquarters, manufacturing site or ownership structure. No parent company, brand owner, website, customer list or commercial availability is established by the supplied filings. [1][5]

One third-party aggregator lists an earlier clearance, K243206, for an air compression massager under the ACM-PLUS-A1 through ACM-PLUS-A6 designations, dated February 19, 2025, attributed to the same company name. That record is not among the numbered sources here and is not counted in the supplied portfolio snapshot, so its details remain unverified in this profile. [6]

How to read the collection figures

The supplied portfolio snapshot, retrieved November 20, 2026, links one record in total, all on the 510(k) pathway, with a decision count of one SESE. The record sample contains the same single entry, K262812, and its sample decision count is likewise one SESE. These are counts of the supplied filings as of that date, not measures of total company output, sales, market position or safety performance. [1][5]